Treace Medical Concepts
TMCI | NASDAQ
$4.42
-$0.85 (-16.13%)
At close: Nov 16, 2026, 4:00 PM ET
$4.58
+$0.16 (+3.62%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-16.13%
(1D)No price chart data available for 1D timeframe.
Rating
35.2
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #655/1021 (Top 64%)
Key Statistics
Market Data
Market Cap $289.77M
1D Range
4.37 5.23
52W Range
1.20 5.34
Valuation (TTM)
PE -5.14
PB 4.70
EV/EBITDA -5.89
Valuation (NTM)
Forward PE N/A
Forward PEG 0.45
Price Target $6.50
Cash Flow
FCF Yield -6.4%
SBC Adj. FCF Yield -16.4%
SBC Impact -156.1%
Margins
Gross Margin 79.5%
Operating Margin -24.4%
FCF Margin -9.1%
Growth (CAGR)
Revenue 3Y | 5Y 5.2% |
19.0%
Dil EPS 3Y | 5Y 7.4% |
-0.9%
FCF 3Y | 5Y 41.9% |
20.1%
Returns
ROA -31.1%
ROE -75.9%
ROIC -35.6%
Financial Health
Net Cash
$27.18M
Current Ratio 2.58
Interest Coverage -8.17
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct ...
Sector Healthcare
Industry Medical - Devices
Employees 450
IPO Date Apr 23, 2021
Website www.treace.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 6, 2026
EPS
-$0.19
Beat +25.20%
YoY:
+26.92% REV
$48.25M
Beat +0.95%
YoY:
-3.91%Next Earnings
Feb 26, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$6.50
Upside
+47.06%
Buy (2)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove TMCI